Cheng Cheng

机构：Dalian Medical University, Second Affiliated Hospital of Dalian Medical University

发表论文 60 篇 · 总被引 2532 次 · h-index 27

代表论文

• Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial (2022 · EClinicalMedicine · 被引 44)
• Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis (2024 · Signal Transduction and Targeted Therapy · 被引 40)
• STING activation in macrophages by vanillic acid exhibits antineoplastic potential (2023 · Biochemical Pharmacology · 被引 40)
• Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation (2025 · Nature Communications · 被引 31)
• Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base (2021 · Cell Reports · 被引 23)
• NOP2-mediated 5-methylcytosine modification of APOL1 messenger RNA activates PI3K-Akt and facilitates clear cell renal cell carcinoma progression (2024 · International Journal of Biological Sciences · 被引 17)